Kenneth F Schulz

发表

Generation of allocation sequences in randomised trials: chance, not choice

Kenneth F Schulz, David A Grimes, K. Schulz, 2002, The Lancet.

Kenneth F Schulz, David A Grimes, K. Schulz, 2008, Obstetrics and gynecology.

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

David Moher, Douglas G Altman, Peter C Gøtzsche, 2013, BMJ.

The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials (Reprinted from JAMA 2001;285:1987-1991)

David Moher, Douglas G Altman, Kenneth F Schulz, 2001 .

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.

David Moher, Douglas G Altman, Isabelle Boutron, 2017, Annals of internal medicine.

Refining clinical diagnosis with likelihood ratios

Kenneth F Schulz, David A Grimes, K. Schulz, 2005, The Lancet.

Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ research

Douglas G Altman, Peter Jüni, Jonathan A C Sterne, 2002, Statistics in medicine.

The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.

David Moher, Kenneth F Schulz, D. Moher, 2005, Explore.

[The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials].

David Moher, Douglas G Altman, Kenneth F Schulz, 2005, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa

David Moher, Douglas G Altman, Larissa Shamseer, 2012, Systematic Reviews.

Peer review of statistics in medical research. Reporting power calculations is important.

David Moher, Douglas G Altman, Kenneth F Schulz, 2002, BMJ.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Exclusions before Randomisation Exclusions after Randomisation Sample Size Slippages in Randomised Trials: Exclusions and the Lost and Wayward

Kenneth F Schulz, David A Grimes, K. Schulz, 2022 .

Multiplicity in randomised trials I: endpoints and treatments

Kenneth F Schulz, David A Grimes, K. Schulz, 2005, The Lancet.

Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.

David Moher, Douglas G Altman, Isabelle Boutron, 2008, Annals of internal medicine.

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, Obstetrics and gynecology.

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, Journal of clinical epidemiology.

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

Douglas G Altman, Richard M Martin, Peter Jüni, 2008, BMJ : British Medical Journal.

Describing reporting guidelines for health research: a systematic review.

Iveta Simera, David Moher, John Hoey, 2011, Journal of clinical epidemiology.

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

David Moher, Sofia Dias, Douglas G Altman, 2012, The Cochrane database of systematic reviews.

[CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration].

David Moher, Elizabeth Wager, Douglas G Altman, 2008, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review

David Moher, John Hoey, Douglas G Altman, 2014, BMJ : British Medical Journal.

Randomised trials, human nature, and reporting guidelines

Kenneth F Schulz, K. Schulz, 1996, The Lancet.

Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research

Iveta Simera, David Moher, John Hoey, 2008, BMC medicine.

Blinding in randomised trials: hiding who got what

Kenneth F Schulz, David A Grimes, K. Schulz, 2002, The Lancet.

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, PLoS medicine.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Trialists Rely on the Security of Unpredictability. in the Forcing Cosmetic Credibility Unequal Group Sizes in Randomised Trials: Guarding against Guessing

Kenneth F Schulz, David A Grimes, K. Schulz, 2022 .

CONSORT 2010 changes and testing blindness in RCTs

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, The Lancet.

Surrogate end points in women's health research: science, protoscience, and pseudoscience.

Kenneth F Schulz, David A Grimes, K. Schulz, 2010, Fertility and sterility.

The Good Clinical Practice guideline: a bronze standard for clinical research

David Moher, Douglas G Altman, Kenneth F Schulz, 2005, The Lancet.

Allocation concealment in randomised trials: defending against deciphering

Kenneth F Schulz, David A Grimes, K. Schulz, 2002, The Lancet.

Improving the reporting of randomised trials: the CONSORT Statement and beyond

David Moher, Douglas G Altman, Kenneth F Schulz, 2012, Statistics in medicine.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

David Moher, Douglas G Altman, Peter C Gøtzsche, 2015, Revista panamericana de salud publica = Pan American journal of public health.